Metabolic studies and therapeutic experiences with the beta-receptor blockader 4- (2-hydroxy-3-isopropylamino-propoxy) -indol (LB 46)
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M.
Arzneimittel-Forschung 22(6): 1055-1061
1972
ISSN/ISBN: 0004-4172 PMID: 4403217 Document Number: 47890
Document emailed within 1 workday
Related Documents
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397Marchetti, G.; Merlo, L.; Noseda, V. 1973: Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601 Bollettino Della Societa Italiana di Cardiologia 18(7): 672-675
Inatomi, N.; Kuriki, H.; Kanno, M.; Kawazoe, K.; Nagawa, Y.; Miyata, T.; Takahama, K.; Kasé, Y. 1980: Pharmacological studies of trans-6-hydroxy-5-hydroxymethyl-2-isopropylamino-1,2,3,4,-tetrahydro-1-naphthalenol hydrochloride (AA-497), a new potent bronchodilator Arzneimittel-Forschung 30(2): 276-285
Rabast, U.; Kasper, H.; Schönborn, J.; Knechtel, B. 1977: Blood glucose concentration and insulin activity in serum after administration of the beta receptor blockader nifenalol-HC1 (INPEA). Studies in metabolically healthy people and diabetics Therapie der Gegenwart 116(6): 1162-1174
Schmidt, E.; Bruch H-P 1978: 1st experiences with the alpha-receptor blockader phentolamine in achalasia Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 49(1): 22-24
Vágfalvy, I.; Fehér, L. 1970: The use of iproveratril (a beta receptor blockader) in the treatment of thyrotixic crisis Orvosi Hetilap 111(12): 685-687
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Gränzer, W.; Eichinger, H. 1982: Inhibition of isoprenaline-induced tachycardia in calves with the beta-receptor blockader carazolol Berliner und Munchener Tierarztliche Wochenschrift 95(3): 47-49
Bergmann, K.; Horák, O. 1970: Trimepranol, a new Czechoslovak sympatholytic beta receptor blockader. I. in angina pectoris therapy Casopis Lekaru Ceskych 109(22): 473-476
Friedemann, M. 1975: Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken) Schweizerische Medizinische Wochenschrift 105(30): 957-961
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
De Petra, V.; Di Michele, R.; Cecchetti, E. 1973: Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris Minerva Cardioangiologica 21(9): 619-624
Dallot, E.; Cedard, L.; Pollet, S.; Nolot, M.; Baumann, N. 1974: Study of 5-hydroxy-indol-acetic acid in amniotic fluid during pregnancy La Nouvelle Presse Medicale 3(38-40): 2503
Zilenovski, A.M.; Freire, C.A.; Iverson, M.T. 1984: Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. a multicenter study Arquivos Brasileiros de Cardiologia 42(6): 435-441
Librowski, T.; Nalepa, I.; Czarnecki, R.; Vetulani, J. 1994: The effect of (-)-4-(2-hydroxy-3(N-isopropylamino)-propoxyimino)-cis-carane on basal and forskolin-stimulated accumulation of cyclic AMP in the cerebral cortical slices of the rat Journal of Pharmacy and Pharmacology 46(5): 393-394
Mellin, C.; Liu, Y.; Hacksell, U.; Björk, L.; Andén, N.E. 1987: A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT) Acta Pharmaceutica Suecica 24(4): 153-160
Floru, L.; Tegeler, J. 1974: Therapeutic significance of the beta-receptor blockade in lithium-induced tremor. Therapeutic trials with Pindolol and Practolol Die Medizinische Welt 25(11): 450
Saczewski, F.; Foks, H.; Sawlewicz, J.; Szulc, K. 1986: Studies of benzimidazole derivatives. XIII. Synthesis of various 2-alpha-hydroxy- and 2-beta-hydroxyalkyl-benzimidazoles Acta Poloniae Pharmaceutica 43(4): 299-307
Hullot, P.; Poudrel, J.M.; Muller, A.; Escale, R.; Rossi, J.C.; Girard, J.P.; Bonne, C. 1997: Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate Arzneimittel-Forschung 47(1): 51-58
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639